• Return to Headlines

Medtronic Plc Shares Up 23.3% Since SmarTrend's Buy Recommendation (MDT)

By James Quinn

SmarTrend identified an Uptrend for Medtronic Plc (NYSE:MDT) on May 3rd, 2019 at $89.49. In approximately 4 months, Medtronic Plc has returned 23.34% as of today's recent price of $110.38.

In the past 52 weeks, shares of Medtronic Plc have traded between a low of $81.66 and a high of $111.18 and are now at $110.55, which is 35% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.3% while the 50-day MA has advanced 0.7%.

Medtronic, PLC develops therapeutic and diagnostic medical products. The Company's principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. Medtronic's products are sold worldwide.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Medtronic Plc shares.

Log in and add Medtronic Plc (MDT) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights medtronic plc

Ticker(s): MDT